NCT06703242 Pilot Study on a Health Promotion Intervention for Ultra-Orthodox Mothers of Children With ADHD
| NCT ID | NCT06703242 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Adina Maeir |
| Condition | Attention Deficit Disorder With Hyperactivity (ADHD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 32 participants |
| Start Date | 2024-11-24 |
| Primary Completion | 2025-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 32 participants in total. It began in 2024-11-24 with a primary completion date of 2025-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to evaluate the feasibility and effectiveness of a health promotion intervention for Ultra-Orthodox Jewish mothers of children with ADHD. This study will examine the impact of a culturally tailored group-based intervention aimed at reducing stress, enhancing health, and improving the well-being of mothers. The main questions this study aims to answer are: 1. Is the intervention feasible for mothers to participate? 2. Does the intervention improve maternal knowledge about ADHD and reduce stigma? 3. Does it help reduce maternal stress and enhance self-care practices? Participants include: Mothers: Ultra-Orthodox Jewish mothers with a child (ages 6-12) diagnosed with ADHD and no other major health conditions in the family (other than ADHD). Educators: School educators with at least 5 years of experience teaching children with ADHD in the Ultra-Orthodox community. What participation involves: Mothers will attend six weekly teletherapy group sessions, with 6-8 mothers per group. They will complete questionnaires before and after the intervention (approximately 30 minutes each) and participate in a 90-minute remote focus group to provide feedback on the program. Educators will attend a single teletherapy group session (90 minutes) during the program (session 5) and participate in a 90-minute remote interview to provide feedback on the program.
Eligibility Criteria
Inclusion Criteria: * mothers of children with ADHD aged 6- 12 years old * Mothers who identify as ultra-orthodox Jews * Child diagnosis was by a licensed medical professional Exclusion Criteria: * Child medical diagnosis other than ADHD
Contact & Investigator
Adina Maeir, PhD
PRINCIPAL INVESTIGATOR
Hebrew University
Frequently Asked Questions
Who can join the NCT06703242 clinical trial?
This trial is open to female participants only, studying Attention Deficit Disorder With Hyperactivity (ADHD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06703242 currently recruiting?
Yes, NCT06703242 is actively recruiting participants. Contact the research team at jennifer.budman@mail.huji.ac.il for enrollment information.
Where is the NCT06703242 trial being conducted?
This trial is being conducted at Jerusalem, Israel.
Who is sponsoring the NCT06703242 clinical trial?
NCT06703242 is sponsored by Adina Maeir. The principal investigator is Adina Maeir, PhD at Hebrew University. The trial plans to enroll 32 participants.